imiquimod has been researched along with Lymphoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, S; Lim, YT; Noh, HJ; Noh, YW; Shin, WJ; Um, SH | 1 |
Beyeler, M; Burg, G; Dummer, R; Morcinek, J | 1 |
Grossman, L; Mena, J; Miller, RL; Shi, Y; Sorrenti, V; Spaner, DE | 1 |
1 review(s) available for imiquimod and Lymphoma
Article | Year |
---|---|
[Cutaneous neoplasms].
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors | 2003 |
2 other study(ies) available for imiquimod and Lymphoma
Article | Year |
---|---|
Hyaluronic acid-supported combination of water insoluble immunostimulatory compounds for anti-cancer immunotherapy.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Cancer Vaccines; Drug Carriers; Female; Hyaluronic Acid; Hydrogen Bonding; Imiquimod; Immunotherapy; Lipid A; Lymphoma; Mice, Inbred BALB C; Mice, Inbred C57BL; Saponins; Solubility | 2017 |
Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll-like receptor-7/8 agonist, imiquimod.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Disease Progression; Humans; Imiquimod; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Male; Signal Transduction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8; Treatment Outcome | 2005 |